Melbourne has first-cheque investors, healthcare specialists, impact funds and access to national venture firms. These 12 providers are organized around the company’s needs, with wider Australian and New Zealand mandates clearly distinguished from a Melbourne office.
Use this list to build a focused research queue. Start with your company’s stage, the evidence you have and the milestone the round should finance. Then choose a small set of relevant providers, confirm the current mandate and plan an appropriate first conversation.
Melbourne capital at a glance
This is a selective, unranked directory of 12 provider families. A venture fund, angel network, co-investor and growth or strategic investor can serve different company needs. The scope column records geographic, institutional or investment-stage context, not a claim that every organization is headquartered locally.
| Provider | Capital route | Investment scope |
|---|---|---|
| Rampersand | Early-stage VC | Australia and New Zealand founders |
| Archangel Ventures | First-cheque VC | Australia-wide |
| Square Peg | VC | Technology companies; regional fit to confirm |
| Blackbird | Multi-stage VC | Australia-New Zealand ecosystem |
| Brandon Capital | Life-sciences VC | Australia, New Zealand and international teams |
| Giant Leap | Impact VC | Climate, health and people |
| AirTree | VC | Australian and New Zealand founders |
| Flying Fox Ventures | Early-stage investor | Australia and New Zealand |
| Scale Investors | Women-led venture fund | Women-led startups |
| Artesian | Multi-strategy manager with venture funds | Asia-Pacific and wider mandates |
| Main Sequence | Deep-tech VC | Australian research and technology ecosystem |
| Tarnagulla Ventures | Healthcare VC | Melbourne-based; global investments |
Separate first-cheque, specialist and scale capital
- For a company still testing the problem, look for an explicit early-stage or first-cheque approach.
- For healthcare or scientific products, prepare development evidence suited to a specialist investor.
- For impact capital, explain how business growth produces a measurable benefit, not merely a broad social purpose.
Illustrative example: a Melbourne clinical-workflow startup distinguishes its software buyer evidence from the clinical evidence required for its particular product. It researches a software route and a healthcare route, then asks each investor a targeted fit question. An impact thesis becomes a separate evidence column rather than a decorative slide.
Avoid this shortcut: A Melbourne headquarters does not establish an Australia-only mandate. Tarnagulla, for example, explicitly describes a global portfolio with substantial US exposure.
12 providers to research
1. Rampersand
Early-stage VC. Australia and New Zealand founders.
Rampersand invests from inception through pre-seed and seed, and lists Melbourne among its locations. Rampersand official information.
Prepare before outreach: Bring the difficult technical or market question your company can answer next, not just a polished growth forecast.
2. Archangel Ventures
First-cheque VC. Australia-wide.
Archangel describes first-cheque and pre-seed investing in Australian founders. Archangel Ventures official information.
Prepare before outreach: Show what you have learned from users and how a first institutional partner would help turn that learning into a business.
3. Square Peg
VC. Technology companies; regional fit to confirm.
Square Peg publishes a technology portfolio and ongoing investment updates, including early institutional rounds. Square Peg official information.
Prepare before outreach: Use its current investment themes and team information to establish fit rather than assuming a Melbourne address is sufficient.
4. Blackbird
Multi-stage VC. Australia-New Zealand ecosystem.
Blackbird describes investing from the beginning of company building and supporting companies through subsequent stages. Blackbird official information.
Prepare before outreach: Explain the long-term ambition and the immediate proof point separately. Broad stage coverage does not remove selection criteria.
5. Brandon Capital
Life-sciences VC. Australia, New Zealand and international teams.
Brandon supports life-sciences companies from proof of concept and seed through commercialisation and expansion. Brandon Capital official information.
Prepare before outreach: Organize scientific, development and commercial milestones into a fundable sequence. A generic SaaS traction deck will not answer the same questions.
6. Giant Leap
Impact VC. Climate, health and people.
Giant Leap invests in technology-driven businesses across climate, health and people, with an explicit measurable-impact lens. Giant Leap official information.
Prepare before outreach: Explain how business growth creates the intended benefit and what evidence would falsify the impact thesis.
7. AirTree
VC. Australian and New Zealand founders.
AirTree backs Australian and Kiwi technology founders and provides public company-building resources. AirTree official information.
Prepare before outreach: Use its thesis and portfolio to identify a partner fit. Its ‘Open Source VC’ library is a resource name, not proof of an open-source-only mandate.
8. Flying Fox Ventures
Early-stage investor. Australia and New Zealand.
Flying Fox provides early-stage capital to Australian and New Zealand companies with global ambitions. Flying Fox Ventures official information.
Prepare before outreach: Show how the first customer segment leads to a larger market without treating international expansion as an unsupported assumption.
9. Scale Investors
Women-led venture fund. Women-led startups.
Scale Investors explicitly backs women-led startups. Scale Investors official information.
Prepare before outreach: Check the fund’s current founder and company criteria directly, and prepare the same commercial evidence expected by other relevant investors.
10. Artesian
Multi-strategy manager with venture funds. Asia-Pacific and wider mandates.
Artesian manages both credit and venture strategies, with specialist venture funds for different industries and geographies. Artesian official information.
Prepare before outreach: Identify the actual venture vehicle and sector team. The manager’s debt products are not interchangeable with venture equity.
11. Main Sequence
Deep-tech VC. Australian research and technology ecosystem.
Main Sequence organizes its investment work around major technical challenges, including industrial productivity, healthcare and decarbonisation. Main Sequence official information.
Prepare before outreach: Frame the scientific breakthrough, route to market and required infrastructure as one commercialization plan.
12. Tarnagulla Ventures
Healthcare VC. Melbourne-based; global investments.
Tarnagulla is Melbourne-based, invests in early-stage healthcare and states that most investments are in US-based companies. Tarnagulla Ventures official information.
Prepare before outreach: Do not infer an Australia-only mandate from its office. Check the scientific and geographic fit before outreach.
Turn the directory into your next five research actions
Choose five providers with a plausible mandate match, not five familiar logos. For each one, keep a source and one unresolved fit question beside the next action. Leave unknown information blank until you can verify it.
A compact investor-fit worksheet
Copy one record per provider. Replace the bracketed fields with company-specific evidence.
Melbourne investor research
Provider: [name and specific fund]
Official source + checked date: [URL, date]
Why our stage and technology fit: [evidence]
Geographic or institutional connection: [evidence]
Milestone this round finances: [specific result]
Open fit question: [one question]
Introduction or founder route: [verified route]
Owner + next action + date: [person, action, date]
Decision: [research next / ask a question / hold]Move a provider forward when the current mandate and your company evidence match. Ask a question when one material criterion is unclear. Hold when the fund is at the wrong stage, serves a different company geography or expects evidence you do not yet have. Do not treat a contact record as investor interest.
Give Aurora, Claude or Codex a focused research mission
Use this prompt with Aurora in Finta, Claude or Codex. Add only material you are authorized to share. Review the result before adding records or contacting anyone.
Be my Melbourne investor-research teammate.
Company: [one sentence, stage and location]
Technology or business model: [specific scope]
Evidence we have: [authorized facts only]
Next financing milestone: [result to fund]
Candidates: [paste five provider names from this guide]
Check each provider's current official sources.
Return: fit evidence, source URL/date, one open question, next action.
Separate local presence, investment reach and eligibility.
Mark missing facts unknown; do not invent cheque sizes or contacts.
Check portfolio conflicts before suggesting sensitive material.
Draft a research queue only. Do not contact or submit to anyone.Keep the next step moving
A useful shortlist connects investor fit to a relationship owner and a specific next action. Use Finta’s investor-prospecting workflow to organize the research. Keep the official source, contact context and follow-up together in your fundraising pipeline.
Before asking for an introduction, review portfolio conflicts and prepare a relevant message. The warm-introduction guide explains how to make a clear, permission-aware request. A possible path is not a completed introduction or a financing commitment.
A common founder question
Should a Melbourne founder only approach local funds?
Not necessarily. National and trans-Tasman firms can be relevant when their mandate matches. Use location to understand access and support, not as a substitute for stage and sector fit.
How this list was researched
Research reviewed on October 28, 2026 using the linked official investment, portfolio and program pages. We count related firms and vehicles as one provider family where noted. Order is not a performance ranking. Public mandate evidence does not establish uncommitted capital, an open application window or an offer to invest; confirm the current process directly. The cover is an illustrative ecosystem, not a literal map or an investor-network diagram.
Authored by Finta Editorial Team. Source review was AI-assisted; hypothetical examples are labelled illustrative and are not customer results.
Informational guidance
This content is for general informational and educational purposes, not personalized investment, financial, legal or tax advice. Finta is not a law firm. Consult your attorney or accountant about financing documents, eligibility, intellectual property, tax treatment and your company’s circumstances.